{
    "ticker": "FGD",
    "name": "Fulgent Genetics, Inc.",
    "description": "Fulgent Genetics, Inc. is a leading provider of comprehensive genetic testing services, specializing in the development and commercialization of innovative technologies for genetic analysis. Founded in 2011 and headquartered in Temple City, California, Fulgent offers a wide array of genetic tests for various applications, including oncology, infectious diseases, reproductive health, and more. The company leverages advanced sequencing technologies and bioinformatics to deliver accurate, timely, and actionable genetic information to healthcare providers and patients. Fulgent's proprietary platforms enable them to provide customized testing solutions tailored to meet the specific needs of their clients. With a commitment to enhancing patient care through genetic insights, Fulgent promotes the understanding of genetic disorders and the development of personalized treatment plans. The company's mission is to empower healthcare providers with the genetic information necessary to improve patient outcomes while making genetic testing more accessible and affordable. Fulgent has also made significant strides in the area of COVID-19 testing, providing high-throughput testing solutions to help combat the pandemic. As a forward-thinking organization, Fulgent Genetics continues to invest in research and development to expand its testing capabilities and solidify its position as a leader in the genetic testing industry.",
    "industry": [
        "Healthcare",
        "Genetics"
    ],
    "headquarters": "Temple City, California, USA",
    "founded": "2011",
    "website": "https://www.fulgentgenetics.com",
    "ceo": "Ming Hsieh",
    "social_media": {
        "twitter": "https://twitter.com/FulgentGenetics",
        "linkedin": "https://www.linkedin.com/company/fulgent-genetics/"
    },
    "investor_relations": "https://investors.fulgentgenetics.com",
    "key_executives": [
        {
            "name": "Ming Hsieh",
            "position": "CEO"
        },
        {
            "name": "Huang Zhang",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "Oncology Testing",
                "Infectious Disease Testing",
                "Reproductive Health Testing"
            ]
        },
        {
            "category": "COVID-19 Testing",
            "products": [
                "PCR Testing",
                "Antigen Testing"
            ]
        }
    ],
    "seo": {
        "meta_title": "Fulgent Genetics, Inc. | Comprehensive Genetic Testing Services",
        "meta_description": "Explore Fulgent Genetics, Inc., a leader in genetic testing services. Discover their innovative testing solutions for oncology, infectious diseases, and more.",
        "keywords": [
            "Fulgent Genetics",
            "Genetic Testing",
            "Oncology Testing",
            "Infectious Disease Testing",
            "COVID-19 Testing"
        ]
    },
    "faq": [
        {
            "question": "What does Fulgent Genetics specialize in?",
            "answer": "Fulgent Genetics specializes in comprehensive genetic testing services across various applications, including oncology, infectious diseases, and reproductive health."
        },
        {
            "question": "Who is the CEO of Fulgent Genetics?",
            "answer": "Ming Hsieh is the CEO of Fulgent Genetics, Inc."
        },
        {
            "question": "Where is Fulgent Genetics headquartered?",
            "answer": "Fulgent Genetics is headquartered in Temple City, California, USA."
        },
        {
            "question": "What types of tests does Fulgent Genetics offer?",
            "answer": "Fulgent Genetics offers genetic tests for oncology, infectious diseases, reproductive health, and COVID-19."
        },
        {
            "question": "When was Fulgent Genetics founded?",
            "answer": "Fulgent Genetics was founded in 2011."
        }
    ],
    "competitors": [
        "NTRA",
        "ILMN",
        "EXAS"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "REGN"
    ]
}